#151874

Anti-BCLAF1 [M33-P5B11]

Cat. #151874

Anti-BCLAF1 [M33-P5B11]

Cat. #: 151874

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 3-4 weeks

Target: BCL2 Associated Transcription Factor 1 (BCLAF1)

Class: Monoclonal

Application: IHC ; WB ; ELISA ; IHC ; WB

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Ayham Alnabulsi

Institute: Vertebrate Antibodies Limited

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-BCLAF1 [M33-P5B11]
  • Research fields: Apoptosis and autophagy;Cancer;Genetics
  • Clone: M33-P5B11
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Strain: Balb/c
  • Reactivity: Human
  • Host: Mouse
  • Application: IHC ; WB ; ELISA ; IHC ; WB
  • Description: BCLAF1 was associated with poor prognosis and showed aberrant localization in colorectal cancer.
  • Immunogen: Peptide Sequence - KYQGDGIVED (amino acids 900 909)
  • Isotype: IgG1 kappa
  • Recommended controls: ELISA- Peptide immunogenWestern Blot- Hela whole cell extractIHC- Human colon carcinoma

Target Details

  • Target: BCL2 Associated Transcription Factor 1 (BCLAF1)
  • Tissue cell line specificity: ELISA- Peptide immunogenWestern Blot- Hela whole cell extractIHC- Human colon carcinoma
  • Target background: BCLAF1 was associated with poor prognosis and showed aberrant localization in colorectal cancer.

Applications

  • Application: IHC ; WB ; ELISA ; IHC ; WB

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Shipping at 4° C

References

  • Brown et al. 2016. Histopathology. 68(4):556-66. PMID: 26183150.
  • The expression and prognostic significance of bcl-2-associated transcription factor 1 in rectal cancer following neoadjuvant therapy.